Valuation: Medios AG

Market Cap 308M 353M 284M 262M 494M 33.97B 505M 3.4B 1.34B 16.64B 1.32B 1.3B 57.28B P/E 2026 *
11.4x
P/E 2027 * 9.01x
Enterprise Value 384M 440M 355M 327M 616M 42.36B 630M 4.24B 1.67B 20.75B 1.65B 1.62B 71.42B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day-1.75%
1 week+3.33%
Current month+2.65%
1 month-2.52%
3 months-7.05%
6 months-15.99%
Current year-14.36%
1 week 11.9
Extreme 11.9
12.58
1 month 11.8
Extreme 11.8
13
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 31/01/2026
Director of Finance/CFO 54 14/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 06/11/2014
Director/Board Member 65 13/09/2016
Director/Board Member 57 09/06/2021
Date Insider Type Main position Quantity % Market Cap.
04/02/26 Sell

Chief Executive Officer

13,638 0.0535%
22/01/26 Buy

Executive/Senior Manager

4,000 0.0157%
19/08/24 Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
-1.43%+3.33%-2.21%-28.32% 353M
+0.78%-0.87%+54.73%+163.51% 1,043B
+1.26%-1.20%+55.79%+59.62% 602B
+1.13%+4.04%+34.85%+91.43% 449B
+0.78%-0.71%+30.04%+24.61% 327B
+1.41%+0.58%+33.92%+47.20% 279B
-0.27%-1.87%+22.13%+23.47% 264B
-1.02%+1.38%+23.52%+61.70% 201B
-0.14%+5.41%+25.78%+76.63% 169B
-0.18%+4.05%+2.32%-29.87% 143B
Average +0.16%-0.27%+28.09%+49.00% 347.74B
Weighted average by Cap. +0.65%-1.82%+40.50%+85.10%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.92B 1.77B 3.34B 229B 3.41B 22.96B 9.03B 112B 8.94B 8.75B 387B 2.14B 2.45B 1.97B 1.82B 3.43B 236B 3.5B 23.58B 9.28B 115B 9.19B 8.99B 397B
Net income 27.41M 31.36M 25.29M 23.31M 43.94M 3.02B 44.91M 302M 119M 1.48B 118M 115M 5.09B 34.51M 39.49M 31.84M 29.35M 55.32M 3.8B 56.55M 381M 150M 1.86B 148M 145M 6.41B
Net Debt 76.15M 87.14M 70.27M 64.77M 122M 8.39B 125M 840M 330M 4.11B 327M 320M 14.15B 40.72M 46.6M 37.58M 34.64M 65.29M 4.49B 66.74M 449M 177M 2.2B 175M 171M 7.57B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
17/07/26 12.40 -1.43% 32,287
16/07/26 €12.58 +2.44% 15,866
15/07/26 €12.28 +1.32% 7,634
14/07/26 €12.12 -0.16% 12,077
13/07/26 €12.14 +1.17% 26,461
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.58EUR
Average target price
23.00EUR
Spread / Average Target
+82.83%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock